On July 20, a class action lawsuit was filed against Abbott Laboratories over its recalled Similac, Alimentum, and EleCare infant formulas. The suit alleges that the company failed to properly warn consumers about the potential dangers of the products.
The recall was announced on July 12 after it was discovered that some of the formulas may have been contaminated with a bacteria that can cause severe gastrointestinal illness. The recalled products were sold in the United States, Puerto Rico, and Guam between March 6 and July 12 of this year.
The lawsuit alleges that Abbott knew or should have known about the potential contamination of its products but failed to take appropriate action to protect consumers. It seeks compensation for those who purchased the recalled formulas.
Similac and Enfamil Baby Formula NEC Risks
The Similac infant formula class action lawsuit is just the latest in a series of legal actions taken against Abbott over its recalled infant formulas. In May, a separate class action was filed over the company's Alimentum and EleCare products. That suit alleged that Abbott failed to properly warn consumers about the risks posed by those products.
The recall of the Alimentum and EleCare products was announced in April, after it was discovered that some of the formulas may have been contaminated with a bacteria that can cause severe gastrointestinal illness. The recalled products were sold in the United States between February 17 and April 7 of this year.
The lawsuit alleges that Abbott knew or should have known about the potential contamination of its products but failed to take appropriate action to protect consumers. It seeks compensation for those who purchased the recalled formulas.
In both cases, the plaintiffs are seeking compensatory and punitive damages from Abbott Laboratories. If you or a loved one has been affected by the recall of Similac, Alimentum, or EleCare infant formula, please contact us today for a free consultation.
